ISSN: 1477-7274
Previously published as: British Journal of Clinical Governance
Online from: 2003
Subject Area: Health Care Management/Healthcare
Content: Latest Issue |
Latest Issue RSS | Previous Issues
Options: To add Favourites and Table of Contents Alerts please take a Emerald profile
Downloads: The fulltext of this document has been downloaded 50 times since 2012
Article citation: , (2012) "Reviews of effectiveness", Clinical Governance: An International Journal, Vol. 17 Iss: 3, pp. -
Vilsboll, T., Christensen, M., Junker, A.E., Knop, F.K., Gluud, L.L.,
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials,
BMJ,
2012,
Vol. 344,
d7771
This well-conducted review concluded that treatment with glucagon-like peptide-1 receptor agonists led to weight loss in overweight or obese patients with or without type 2 diabetes. This conclusion is likely to be reliable for short-term treatment, although the evidence was stronger for people with diabetes than those without.